Ruolo dell' odontoiatra nella prevenzione dell' osteonecrosi da bifosfonati

Translated title of the contribution: Dentist's role in preventing biphosphonates induced osteonecrosis

Sabrina Pappalardo, L. Tanteri, V. Carlino, S. Distefano, S. Santapaola, F. La Ferla, E. Gherlone

Research output: Contribution to journalArticlepeer-review


The bisphosphonates are good inbibitors of osteoclastic activity and have antiangionenic properties. They are used in the treatment of post-menopausal osteoporosis, Paget's disease and malignant hypercalcemia. Some bisphosphonates, such as pamidronate or zoledronate, are stronger and are indicated in the treatment of breast and prostate cancer in order to reduce the risk of bone metastasis, and in the treatment of multiple myeloma for bone resorptive defects and to prevent pathological fractures. Recently several Authors have reported cases of jaw osteonecrosis in patients treated with bisphosphonates. The dentist may play an important role in preventing this complication induced by bisphosphonates through diagnosis and control of oral diseases. It is necessary that patients have good oral health before being treated with bisphosphonates.

Translated title of the contributionDentist's role in preventing biphosphonates induced osteonecrosis
Original languageItalian
Pages (from-to)27-40
Number of pages14
JournalItalian Oral Surgery
Issue number5
Publication statusPublished - Nov 2008

ASJC Scopus subject areas

  • Oral Surgery
  • Orthodontics


Dive into the research topics of 'Dentist's role in preventing biphosphonates induced osteonecrosis'. Together they form a unique fingerprint.

Cite this